aifollow.news Search
Back Rohan Paul
Rohan Paul· @rohanpaul_ai · X· · Original publication time AI score54

Claude designs scorpion-toxin-binding proteins; 17 of 211 tested designs bindMachine translation

Automatically verified and published · Generated and evidence-checked automatically; not reviewed by a human.

AI introduction

In Anthropic’s Claude Science setup, Claude selected toxin targets, directed 12 protein-design programs, and chose 180 of 318,484 generated molecules for physical synthesis. The source reports that 17 of 211 designs tested at Adaptyv Bio and Twist Bioscience bound their target toxins. Anthropic is not calling the result an antivenom because the test needed to justify that term has not yet been run.

Original post · Original

The article text is unavailable in this language; an existing version is shown.

@rohanpaul_ai

https://t.co/KUbecwCIdr

ReplyRohan Paul@rohanpaul_ai
Claude did the protein scientist’s job and came back with 17 molecules that grip scorpion neurotoxins. Claude, running as an agent inside Anthropic’s Claude Science setup, ran the whole protein-design campaign itself: it picked which patch of each scorpion toxin to attack, drove 12 protein-design programs, set its own scoring cutoffs, and chose 180 molecules out of the 318,484 it generated for physical synthesis, and 17 of the 211 designs tested bound their toxin at Adaptyv Bio and Twist Bioscience. Citrini Research, a finance firm with no lab and no protein expertise, asked for this work, and Claude designed proteins that two labs confirmed latch onto scorpion venom toxins. Scorpion stings kill more than 3,250 people a year, so the prize is real, if this method works. However, Anthropic is not calling this an antivenom, because the test that would justify the word has not been run yet.
View this post on X ↗
Related contextAnthropic@AnthropicAI
New on our Science Blog: designing protein binders against scorpion neurotoxins. Scorpions sting about 1.2m people every year, and antivenoms are often costly or in short supply. Claude has made an early step toward finding new treatments. https://t.co/l6LgdEqM7I
View this post on X ↗

来源:Rohan Paul · x.com

Research
Found an error? Send a correction